Zasocitinib
CAS 2272904-53-5
In Stock
Zasocitinib
Cat. No. STUB-API-ZASOCITINIB-APICAS 2272904-53-5In Stock
Technical Data
Cat. No.STUB-API-ZASOCITINIB-API
CAS2272904-53-5
Mol. FormulaC23H24N8O3
Mol. Weight460.498 g/mol
IUPACN-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-yl-3-pyridinyl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCNC1=CC(=NC2=C(C=NN12)C(=O)N[C@@H]3CC[C@H]3OC)NC4=CC=CN(C4=O)C5=CC=CC=N5
InChIInChI=1S/C23H24N8O3/c1-24-20-12-18(27-16-6-5-11-30(23(16)33)19-7-3-4-10-25-19)29-21-14(13-26-31(20)21)22(32)28-15-8-9-17(15)34-2/h3-7,10-13,15,17,24H,8-9H2,1-2H3,(H,27,29)(H,28,32)/t15-,17-/m1/s1
InChI KeyBWINBHTTZLVXGT-NVXWUHKLSA-N
Purity—
Description
Overview
Zasocitinib (formerly TAK-279) is an oral, highly selective, allosteric tyrosine kinase 2 (TYK2) inhibitor being developed by Takeda Pharmaceuticals for inflammatory conditions, including moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease
Anant Labs manufacture and furnish high quality Zasocitinib impurities for global markets. Our Zasocitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
2272904-53-5N-((1R,2R)-2-Methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-[1,2'-bipyridin]-3-yl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxamideN-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo[1(2H),2'-bipyridin]-3-yl)amino]-pyrazolo[1,5-a]pyrimidine-3-carboxamideN-((1R,2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo(1(2H),2'-bipyridin)-3-yl)amino)-pyrazolo(1,5-a)pyrimidine-3-carboxamideN-((1R,2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-(1,2'-bipyridin)-3-yl)amino)pyrazolo(1,5-a)pyrimidine-3-carboxamideRefChem:822799957-394-0960-464-3ZasocitinibNDI-034858
